Exalenz Bioscience Ltd.

Exalenz Bioscience creates cutting-edge diagnostic and monitoring platforms, which analyze minute changes in a patient’s exhaled breath. Specializing in noninvasive H. pylori and liver function diagnostics, our patented BreathID technology delivers immediate results with industry leading specificity and sensitivity. The BreathID platform offers a user-friendly interface and a cost-effective clinical diagnostic solution that can be used in any clinical setting, including laboratories, hospitals, point-of-care and the ICU. Driven by excellence as our core value, Exalenz Bioscience is committed to creating innovative diagnostics for management and monitoring of a broad range of GI and liver disorders. We make testing convenient for patients and simple to administer for healthcare professionals. In the last two decades, Exalenz point-of-care BreathID technology has consistently been the most advanced C13 Urea Breath Testing solution on the market. The new BreathID Hp Lab System combines the unprecedented BreathID® clinical accuracy with intuitive workflow automation to provide laboratories an efficient, economic and comprehensive solution for H. pylori detection. The BreathID system is FDA cleared and approved by CE, CFDA, COFEPRIS, HSA and additional countries.